Omalizumab improves efficacy of oral immunotherapy for multiple food allergies
Combination allows more than 80 percent of children to safely consume at least two foods to which they were allergic.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: Allergy | Allergy & Immunology | American Health | Children | Food Allergy | Immunotherapy | National Institutes of Health (NIH) | Xolair